eMedevents

Activity Objectives:

Incorporating New Diabetes Treatments : Rx for Therapeutic Inertia is organized by Boston University School of Medicine Continuing Medical Education and will be held during Jun 15, 2016 - Jun 15, 2018.

The target audience for this medical event is Physicians, physician assistants, NPs, and other allied healthcare professionals.

Conference Objectives are :
Part 1-Using Non-insulin Agents At the completion of this module the learner will :
• Identify the 12 classes of diabetes medications.
• Explain how non-insulin agents address the main pathophysiologic defects of T2DM.
• Recognize the benefits and risks of the newer non-insulin agents for T2DM: DPP-4 inhibitors, GLP-1 RAs and SGLT-2 inhibitors.
• Apply knowledge of metabolic staging of T2DM to initiate and advance therapy, particularly with the newer non-insulin agents .
Part 2- Using Insulin At the completion of this module the learner will :
• List circumstances when insulin should be started in T2DM.
• Recognize the action profiles and dosing strategies of commonly used insulins.
• Initiate and advance insulin therapy in T2DM.
• Comfortably practice the combined use of basal and prandial insulins.

Additional details will be posted as soon as they are available.

Intended Audience

Endocrinology, Metabolism and Diabetes

Activity Payment Details

Activity Fee : Free

Rate this CME (Min 1 - Max 5)

Duration:
Fee and expenses:
CME credits:
Program contents:
Networking:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy

Organizer(s)

Boston University School of Medicine Continuing Medical Education (BUSM CME)

View Organizer Details

Help

617.638.4605, 800.688.2475, 617-638-5300